
==== Front
BMC Nephrol
BMC Nephrol
BMC Nephrology
1471-2369
BioMed Central London

3737
10.1186/s12882-024-03737-1
Research
Impact of arteriovenous fistula aneurysms on a UK dialysis populations’ perception of vascular access
Khawaja A. Z. 1
Ellis J. 1
Hodson J. 2
Inston N. G. 1
Field Melanie melfield@doctors.org.uk

1
1 grid.415490.d 0000 0001 2177 007X Department of Renal Transplantation and Dialysis Access Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham, Edgbaston, Birmingham, West Midlands, B15 2TH UK
2 grid.412563.7 0000 0004 0376 6589 Research Development and Innovation, Institute of Translational Medicine, Queen Elizabeth Hospital, University Hospitals Birmingham, Edgbaston, Birmingham, West Midlands UK
10 9 2024
10 9 2024
2024
25 2998 4 2024
29 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Clinically-oriented outcome measures are increasingly being recognized as lacking in consideration of factors important to patients. There is an emerging move of guideline bodies advocating a more patient-centred approach. Aneurysms in autogenous arteriovenous fistula (AVF) can be considered unsightly and a constant reminder for patients of their dependence on dialysis. However, their impact on patient’s perception has not previously been reported.

Methods

Between April 2017–18, the Vascular Access Questionnaire (VAQ) was administered to prevalent haemodialysis patients across ten dialysis units via structured interviews, as part of a quality improvement project. Data for the subgroup of patients with aneurysmal AVF (categorised as per classification by Valenti et al.), were retrospectively evaluated and compared to the wider cohort.

Results

Data were collected for 539 patients (median age: 66 years; 59% male), of whom 195 (36%) had aneurysmal AVF, with Type 2 morphology (cannulation site) being the most common (75%). Duration of AVF was found to be significantly associated with aneurysmal development, with estimated likelihoods of 11%, 43% and 61% after one, five and ten years, respectively. Interestingly, patients with diabetes had a significantly lower prevalence of aneurysmal development than those that were non-diabetic (25% vs. 43%, p < 0.001). Overall VAQ scores were not found to differ significantly by aneurysm status (p = 0.816) or across morphology types (p = 0.277). However, patients with aneurysmal AVF were significantly more concerned with the appearance of their AVF (p < 0.001) than the wider cohort. Despite this, patients with aneurysmal AVF gave significantly higher scores for satisfaction and ease of use and lower scores for bruising and clotting (p < 0.05).

Conclusions

Aneurysmal AVF are often cited as an important factor by patients for not proceeding with fistula formation. In this evaluation of patient reported experiences, those with aneurysmal AVF reported high satisfaction levels. This may help clinicians highlight positive patient reported outcomes of aneurysmal AVF during preprocedural consent processes.

Keywords

Vascular access
End stage renal failure
Haemodialysis
Patient reported outcomes
Vascular access questionnaire
Aneurysm
Patient experience
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Guidelines and improvement initiatives regarding a permanent form of vascular access (VA) for dialysis suggest an optimum access pathway of arteriovenous fistulas (AVF) over arteriovenous grafts (AVGs), with tunnelled central venous catheters (TCVCs) as a last choice [1–5]. However, emerging updates have suggested a trend towards a more patient tailored theme of “the right access for the right patient at the right time” [6]. Clinically orientated “hard” outcome measures are increasingly being recognized as lacking in consideration of factors important to patients, and may not be the only way of comparing options for the patient [7–9].

Aneurysms within AVF are reported as being relatively common, although the reported incidence differs considerably between studies, ranging from 5–60% [10–14]. These may necessitate surveillance, and potentially require intervention [15]. Whilst there are debates on the most appropriate definitions and classifications of AVF aneurysms, consensus opinion seems to suggest an expansion of the vessel wall to over 18 mm is a reasonable definition [11, 16]. AVF aneurysms are a very visible and often considered unsightly reminder of a patient’s dependence on dialysis. The cosmetic aspects are cited as a potential reason by patients for refusing AVF [17, 18].

The reporting of patient perspectives is slowly increasing in the published literature [19–23]. Whilst descriptions and classifications have been developed for aneurysms in AVF, to the best of our knowledge, the impact of these from the patient’s perspective has not been extensively reported [11, 15]. As part of a quality improvement audit, the Vascular Access Questionnaire (VAQ), described by Quinn et al. and consisting of a patient-reported questionnaire composed of 17 VA related questions, which are scored on a 0–4 Likert scale, was administered to a large regional dialysis population at a tertiary referral centre, to identify patient characteristics that influence their perceptions and outcomes of VA for dialysis [21].

In this paper, we analysed the subgroup of patients with clinically-identified aneurysmal AVF, and compared their results to the remainder of the AVF cohort, as well as comparing across the different morphological types. This analysis included demographic factors, presence of other medical conditions, duration of dialysis and previous access, satisfaction with access and ease of use.

Methods

Between April 2017 and April 2018, the VAQ was administered to established haemodialysis patients at ten dialysis units within a UK region (West Midlands) served by a single tertiary referral centre. The aim of this analysis was to further characterise the sub-group of patients with clinically identified aneurysmal AVF and compare their results to the remainder of the cohort with arteriovenous fistulas without aneurysms, and to compare between the different aneurysmal types.

All patients undergoing haemodialysis in the centres who were able to consent and did not present a linguistic barrier were approached. Patients undergoing acute in-patient dialysis or home haemodialysis were excluded. Data collected also included clinical diagnosis of aneurysmal AVF presence, based on physical examination by members of the team administering the questionnaire. These were classified according to the types as proposed by Valenti et al. [11]. This classification was chosen as it is undertaken on the basis of external appearance and without the requirement for ultrasound assessment.

The VAQ was verbally administered in the patient’s preferred language by clinicians who specialise in working with the target population and disease process to patients whilst they were undergoing dialysis. Questions were asked using the terminology and phrases in common use by clinicians at a patient’s dialysis unit; this was considered sufficient for the purposes of linguistic validation in the context of this study. Data relating to patient health and co-morbidity, including the presence of diabetes and its management, was gained on direct questioning. For patients who elected not to participate, the reasons for non-participation were recorded, and have been reported previously, along with further details of the survey process [24]. Data was collated and managed using REDCap electronic data capture instrument hosted at the University of Birmingham, and exported for analysis to IBM SPSS version 22 (IBM Corp. Armonk, NY), and GraphPad Prism version 7.0 (GraphPad Software, San Diego, Calif. USA) [25]. Institutional audit committee approval was obtained (CARMS-12695).

Statistical methods

Comparisons between patients with and without aneurysmal AVF were performed using Mann-Whitney U tests for continuous or ordinal variables. Nominal factors were analysed using Fisher’s exact test, where possible, with Chi-square tests used where there were too many categories for an exact test to be calculable. These analyses were then repeated for the subgroup of patients that developed aneurysmal AVF, to allow comparisons across the aneurysm morphological types. Further assessment of significant variables was performed using univariable binary logistic regression models. Prior to the analysis, the goodness of fit of factors were assessed using Hosmer-Lemeshow tests, with transformations (e.g. logarithmic) applied where significant poor fit was detected. Throughout the analysis, p < 0.05 was deemed to be indicative of statistical significance.

Results

Patient demographics

Of the dialysis cohort of 920 patients, 749 completed the questionnaire. Of those who did not complete the questionnaire 64.3% (n = 110) were not present at the time of the visit to their dialysis unit, 16.4% (n = 28) did not want to participate and 19.3% (n = 33) could not consent. From this cohort of 749 there were 539 patients who were achieving dialysis through a native arteriovenous fistula were included in the analysis. These patients had a median age of 66 years (Interquartile range (IQR): 56–76), and the majority were male (59%) and of White (50%) or Asian (36%) racial background. The median duration of haemodialysis was 4 years (IQR 2–7), of which a median of 3 years (IQR 1–6) was on the current AVF. Most patients had brachiocephalic (51%) or radiocephalic (39%) AVF, with brachiobasilic AVF in the remainder (10%). All patients underwent standard sharp needles for cannulation with the aim of developing ropeladder cannulation tracts. A total of 195 (36%) AVF were clinically classed as aneurysmal, of which 40 (21%) were of type 1 morphology, 146 (75%) were type 2, and 9 (5%) were type 3, which was in keeping with reported literature. Due to the small number of type 3 aneurysms, these were combined with type 2 aneurysms for subsequent analysis; this was deemed clinically appropriate since type 3 aneurysms are a natural progression from type 2b.

Factors associated with aneurysmal AVF

Of the demographic factors, aneurysmal AVF rates were not found to differ significantly with age (p = 0.255), gender (p = 0.927) or racial background (p = 0.198) (Table 1).

Table 1 Comparisons of patient demographics between those with non-aneurysmal and aneurysmal AVFs, and across aneurysm types

	Aneurysmal AVF	Morphology of Aneurysm	
N	No	Yes	p-Value	N	Type 1	Type 2–3	p-Value	
Age (Years)	539	65 (56–75)	68 (56–77)	0.255	195	66 (48–76)	70 (56–77)	0.087	
Gender				0.927				0.589	
 Female	221	142 (64%)	79 (36%)		79	18 (23%)	61 (77%)		
 Male	318	202 (64%)	116 (36%)		116	22 (19%)	94 (81%)		
Racial background				0.198				0.438	
 White	269	162 (60%)	107 (40%)		107	24 (22%)	83 (78%)		
 Asian	193	133 (69%)	60 (31%)		60	9 (15%)	51 (85%)		
 Black	75	47 (63%)	28 (37%)		28	7 (25%)	21 (75%)		
 Mixed	1	1 (100%)	0 (0%)		0	-	-		
Peripheral Vascular Disease				0.787				0.794	
 No	471	302 (64%)	169 (36%)		169	34 (20%)	135 (80%)		
 Yes	68	42 (62%)	26 (38%)		26	6 (23%)	20 (77%)		
Heart Problems				0.154				0.855	
 No	359	237 (66%)	122 (34%)		122	26 (21%)	96 (79%)		
 Yes	180	107 (59%)	73 (41%)		73	14 (19%)	59 (81%)		
Diabetes				< 0.001				0.088	
 No	326	185 (57%)	141 (43%)		141	35 (25%)	106 (75%)		
 Diet Controlled	51	35 (69%)	16 (31%)		16	1 (6%)	15 (94%)		
 Tablet Controlled	33	28 (85%)	5 (15%)		5	1 (20%)	4 (80%)		
 Insulin	129	96 (74%)	33 (26%)		33	3 (9%)	30 (91%)		
Unit				0.053*				0.461*	
 1	68	36 (53%)	32 (47%)		32	9 (28%)	23 (72%)		
 2	71	37 (52%)	34 (48%)		34	4 (12%)	30 (88%)		
 3	36	23 (64%)	13 (36%)		13	2 (15%)	11 (85%)		
 4	61	43 (70%)	18 (30%)		18	4 (22%)	14 (78%)		
 5	27	22 (81%)	5 (19%)		5	2 (40%)	3 (60%)		
 6	30	21 (70%)	9 (30%)		9	1 (11%)	8 (89%)		
 7	100	68 (68%)	32 (32%)		32	7 (22%)	25 (78%)		
 8	43	32 (74%)	11 (26%)		11	0 (0%)	11 (100%)		
 9	47	27 (57%)	20 (43%)		20	6 (30%)	14 (70%)		
 10	56	35 (63%)	21 (38%)		21	5 (24%)	16 (76%)		
Data are reported as N (row %), with p-values from Fisher’s exact tests, or as median (interquartile range), with p-values from Mann-Whitney U tests, unless stated otherwise. Bold p-values are significant at p < 0.05. *p-Value from Chi-square test

Patients with diabetes were found to be significantly less likely to have aneurysmal AVF, with rates being lowest in tablet-controlled diabetics at 15%, compared to 43% in non-diabetics (p < 0.001). There was also considerable variability in the aneurysmal AVF rates across the ten centres included in the study, ranging from 19 to 48%, although this did not reach statistical significance (p = 0.053). Within those that had developed aneurysms, none of the demographic factors considered were found to be significantly associated with the type of morphology (Table 1).

Of the dialysis-related factors considered, aneurysmal AVF rates were not found to differ significantly between the different AVF types (p = 0.659) (Table 2). This is perhaps interesting given the perception that radiocephalic fistulas are traditionally felt to be more at risk of aneurysmal change, however, it may be that this reflects the longevity of the radiocephalic fistulas in comparison to the brachiocephalic however this was not adjusted for in this cohort.

Table 2 Comparisons of dialysis-related factors between those with and without aneurysmal AVF, and across aneurysm types

	Aneurysmal AVF	Morphology of Aneurysm	
N	No	Yes	p-Value	N	Type 1	Type 2–3	p-Value	
Duration of Haemodialysis (Years)	539	3 (1–5)	7 (4–10)	< 0.001	195	5 (3–8)	7 (4–10)	0.046	
Duration Current Access (Years)	503	2 (1–4)	6 (4–9)	< 0.001	178	4 (2–8)	6 (4–9)	0.008	
Current Fistula				0.659				0.010	
 Brachiobasilic	53	34 (64%)	19 (36%)		19	4 (21%)	15 (79%)		
 Brachiocephalic	272	168 (62%)	104 (38%)		104	29 (28%)	75 (72%)		
 Radiocephalic	211	139 (66%)	72 (34%)		72	7 (10%)	65 (90%)		
Fistula/Graft on Dominant Arm				0.061				0.240	
 No	427	264 (62%)	163 (38%)		163	31 (19%)	132 (81%)		
 Yes	112	80 (71%)	32 (29%)		32	9 (28%)	23 (72%)		
Any Previous Access**				< 0.001				0.605	
 No	477	288 (60%)	189 (40%)		189	38 (20%)	151 (80%)		
 Yes	62	56 (90%)	6 (10%)		6	2 (33%)	4 (67%)		
Previous Line**				< 0.001				0.500	
No	484	292 (60%)	192 (40%)		192	39 (20%)	153 (80%)		
Yes	55	52 (95%)	3 (5%)		3	1 (33%)	2 (67%)		
Number of Previous Lines				0.213*				0.705*	
 0	225	150 (67%)	75 (33%)		75	15 (20%)	60 (80%)		
 1 to 5	289	179 (62%)	110 (38%)		110	22 (20%)	88 (80%)		
 6 to 10	19	12 (63%)	7 (37%)		7	0 (0%)	7 (100%)		
 > 10	5	2 (40%)	3 (60%)		3	3 (100%)	0 (0%)		
Radiology Intervention on Fistula**				0.144				0.047	
 No	409	254 (62%)	155 (38%)		155	27 (17%)	128 (83%)		
 Yes	130	90 (69%)	40 (31%)		40	13 (33%)	27 (68%)		
Data are reported as N (row %), with p-values from Fisher’s exact tests, or as median (interquartile range), with p-values from Mann-Whitney U tests, unless stated otherwise. Bold p-values are significant at p < 0.05. *p-Value from Mann-Whitney U test, as the factor is ordinal. **In the last year

However, patients with aneurysmal AVF were found to have significantly longer durations of haemodialysis (median 7 vs. 3 years, p < 0.001) and of the current access (6 vs. 2 years, p < 0.001). Further analysis of the former returned an odds ratio of 2.13 (95% CI: 1.80–2.53, p < 0.001) per doubling of haemodialysis duration, with an estimated likelihood of developing aneurysms of 11%, 43% and 61% after one, five and ten years of dialysis, respectively (Fig. 1).

Fig. 1 Association between the duration of haemodialysis and aneurysmal AVF rates. Points and whiskers represent the observed rates within percentiles of the distribution, with 95% confidence intervals, and are plotted at the midpoint of the interval. The trendline is from a binary logistic regression model, with Log2 [duration of haemodialysis] as a covariate. The log-transformation was applied in order to improve model fit, as the Hosmer-Lemeshow test indicated significant poor fit when using the untransformed variable (p = 0.009). The resulting model returned an odds ratio for aneurysmal AVFof 2.13 (95% CI: 1.80–2.53, p < 0.001) per doubling of haemodialysis duration

Patients with type 2–3 aneurysmal AVF had significantly longer durations of haemodialysis (median: 7 vs. 5 years, p = 0.046) and of the current access (6 vs. 4 years, p = 0.008) than those with type 1 aneurysms (Table 2). This subgroup analysis also found that, where aneurysms developed, these were significantly more likely to be type 2–3 in radiocephalic AVF (90%), than in brachiocephalic (72%) or brachiobasilic (79%) AVF (p = 0.010). Patients who had undergone radiological intervention in the previous year were significantly less likely to have had type 2–3 aneurysms than those that did not (68% vs. 83%, p = 0.047).

Regarding patient views, those who reported greater degrees of satisfaction (p = 0.022) and ease of use (p = 0.010) were significantly more likely to have aneurysmal AVF (Table 3).

Table 3 Comparisons of patient views between those with and without aneurysmal AVF, and across aneurysm types

	Aneurysmal AVF	Morphology of Fistula	
N	No	Yes	p-Value	N	Type 1	Types 2–3	p-Value	
Satisfaction with Current Access				0.022				0.208	
 Very Dissatisfied	3	3 (100%)	0 (0%)		0	-	-		
 Somewhat Dissatisfied	4	4 (100%)	0 (0%)		0	-	-		
 Somewhat Satisfied	36	27 (75%)	9 (25%)		9	0 (0%)	9 (100%)		
 Very Satisfied	495	309 (62%)	186 (38%)		186	40 (22%)	146 (78%)		
Recommend Current Access				0.108				0.557	
 No	13	6 (46%)	7 (54%)		7	1 (14%)	6 (86%)		
 Maybe Not	6	1 (17%)	5 (83%)		5	2 (40%)	3 (60%)		
 Maybe	26	17 (65%)	9 (35%)		9	0 (0%)	9 (100%)		
 Yes	493	319 (65%)	174 (35%)		174	37 (21%)	137 (79%)		
Access Easy to Use?				0.010				0.279	
 Very Difficult	2	1 (50%)	1 (50%)		1	0 (0%)	1 (100%)		
 Somewhat Difficult	20	15 (75%)	5 (25%)		5	1 (20%)	4 (80%)		
 Somewhat Easy	82	62 (76%)	20 (24%)		20	2 (10%)	18 (90%)		
 Very Easy	433	265 (61%)	168 (39%)		168	37 (22%)	131 (78%)		
Data are reported as N (row %), with p-values from Mann-Whitney U tests. Bold p-values are significant at p < 0.05

Within those developing aneurysms, none of the patient views considered were found to be significantly associated with the classified type of aneurysmal morphology.

VAQ scores

For the whole cohort, the VAQ score followed a positively skewed distribution, with a median of 3 (IQR 1–7) and mean of 5.07. The total VAQ score was not found to differ significantly between those with and without aneurysmal AVF (mean: 5.22 vs. 4.99, p = 0.816, Fig. 2a) or between type 2–3 and 1 aneurysms (mean 5.06 vs. 5.80, p = 0.277, Table 4).

Table 4 Comparisons of the VAQ score between those with and without aneurysmal AVFs, and across aneurysm types

	Aneurysmal AVF	Morphology of Aneurysm	
No	Yes	p-Value	Type 1	Types 2–3	p-Value	
Total VAQ score	4.99	5.22	0.816	5.80	5.06	0.277	
Bleeding	0.28	0.23	0.167	0.28	0.22	0.548	
Pain	0.27	0.25	0.863	0.20	0.26	0.673	
Bruising	0.33	0.24	0.030	0.33	0.22	0.272	
Swelling	0.18	0.13	0.064	0.08	0.15	0.432	
Redness	0.03	0.03	0.778	0.00	0.04	0.583	
Infection	0.01	0.01	1.000	0.00	0.01	1.000	
Clotting	0.18	0.07	0.004	0.08	0.06	0.696	
Appearance	0.25	0.65	< 0.001	1.03	0.55	0.016	
Worries Working Well	0.41	0.47	0.782	0.43	0.48	0.256	
Worries About Hospitalisation	0.31	0.35	0.630	0.38	0.34	0.961	
How Long Access Will Last	0.52	0.58	0.541	0.65	0.56	0.442	
Protecting your Access	0.50	0.49	0.849	0.43	0.51	0.370	
Attending Dialysis Early	0.24	0.16	0.303	0.18	0.15	0.885	
Leaving Dialysis Late	0.42	0.39	0.847	0.58	0.34	0.282	
Problems Sleeping	0.60	0.72	0.303	0.80	0.70	0.496	
Interfering with ADL	0.22	0.22	0.778	0.18	0.23	0.704	
Interfering Leisure Activities	0.24	0.23	0.961	0.23	0.23	0.917	
Data are reported as means, with p-values from Mann-Whitney U tests. Bold p-values are significant at p<0.05. VAQ-vascular access questionnaire, ADL-activity of daily living

Fig. 2 Comparisons of the Vascular Access Questionnaire (VAQ) score between those with and without aneurysmal AVF. Data for the overall VAQ score is plotted, along with components of the score that were found to differ significantly in those with aneurysmal AVF, as per the analysis in Table 4. Unlabelled bars represent < 10% of the cases

Analysis of the individual components of the VAQ score found patients with aneurysmal AVF to have significantly lower (better) scores for bruising (mean: 0.24 vs. 0.33, p = 0.030) and clotting (0.07 vs. 0.18, p = 0.004). However, patients with aneurysmal AVF had significantly higher (worse) scores for the appearance component of the score (mean 0.65 vs. 0.25, p < 0.001, Fig. 2b). A subgroup analysis on the appearance component of the VAQ found those with type 2–3 aneurysms to have significantly lower (better) scores than those with type 1 aneurysms (mean: 0.55 vs. 1.03, p = 0.016).

Discussion

Within this large cohort of patients, the overall aneurysmal AVF rate was 36%, as evaluated clinically on physical examination. This is broadly in line with the quoted incidence reported by Valenti et al., and is the classification we at our centre use in our daily practice [11].

The lower rate of aneurysm formation in AVF amongst diabetics is consistent with larger studies investigating the association with diabetes and lower rates of abdominal aortic aneurysm development, or slower growth, although the reasons for this are not entirely clear [26]. The potential for diabetic medication to slow aneurysm growth has been suggested based on experimental and clinical data, and this would appear to be supported in this data on AVF [27]. However, it must be acknowledged that development of aneurysms in the setting of AVF is associated with cannulation in contrast to their development in aortic aneurysm disease [16].

This dataset confirms the logical conclusion that the likelihood of developing an aneurysm is increased with increasing longevity of the AVF. For the purposes of pre-operative consent, it may be useful to give an indication that for an AVF that is still being used for ten years, there is a 60% chance of it becoming aneurysmal. Similarly, within those patients that developed AVF aneurysms, those with type 2–3 morphology tended to have longer AVF duration.

Patients with aneurysmal AVF reported significantly higher satisfaction with their access while at the same time reporting worse scores for appearance, especially in type 1 morphology. Hypothetically, this might relate to aneurysmal AVF being inherently easier to cannulate. The combination of these two findings suggests that, although the appearance of aneurysmal AVF is a deterrent to creation of AVF for patients, this is offset by an improvement in ease of use and may not be sufficient to render patients dissatisfied with their access in the longer term. It should be recognised however, that patients may be satisfied with their fistula but may not offset this with the potential need for further intervention due to the aneurysm. As such, the ability to create an AVF with a lower risk of aneurysmal formation would be of benefit in this situation, if the appearance concern is a significant enough issue to deter AVF formation [28]. In addition, the high level of satisfaction with aneurysmal AVF would be a useful component of discussion with new patients at the outpatient clinic.

Wide variation existed between our units in terms of rate of aneurysmal AVF (19–48%), which narrowly missed statistical significance (p = 0.053). It is conceivable that this difference between units could relate to different practices and levels of experience of dialysis nurses with respect to cannulation and represents an area of practice that could be targeted to improve outcomes. As particular cannulation practice (buttonhole, rope-ladder, area-cannulation or combinations) was not captured at initial data collection, this would require further exploration, and would be targeted in the subsequent audit and quality improvement cycles.

In keeping with traditional teaching on arterial aneurysms, size based quantitative analysis may be a useful prognostic factor, and merit evaluation quantitatively. However, this was not within the scope of this evaluation of patient perceptions of AVF aneurysms. It could additionally be argued that these vary widely, and a size cut off of growth in millimetres or increase per year may not be an appropriate measure to use in patient satisfaction evaluation. Capturing differences in perceptions may be more appropriate when using a clinical physical evaluation-based classification, such as that proposed by Valenti el al., which was the approach used in the present study. Such an approach may also be more in line with what the patient is “seeing” on their arm.

The authors acknowledge the importance of aneurysmal morphology quantification and risk factors such as cannulation practice, high flow, pre-existing comorbidities and temporal trends in combination with size-based classification. The authors also acknowledge that the VAQ was administered only once, and further longitudinal analysis to capture changing patient views alongside the natural history of AVF that evolve into specific morphology is required. This is an often neglected area of study, which in our experience is labour intensive and has multiple influencing factors. Nevertheless, we believe this would be useful in evaluating management methods or possibly cannulation techniques for reducing risks associated with AVF aneurysms and would form part of future work.

The authors are not aware of any previous published studies reporting in such detail of a large dialysis population of over 500 patients and aneurysmal AVF, catered to by a single tertiary centre. We equally do also acknowledge this forms an early building block for this evidence base and further work is required to gather pertinent data on patient perspectives.

Conclusions

This is the first report the authors are aware of that examines the impact of aneurysmal AVF from the patient perspective. In this cohort, whilst the presence of an aneurysm was associated with concerns regarding appearance, interestingly, it did not reduce patients’ overall satisfaction with their AVF. This might be expected, given the perception that these AVF are easier to cannulate, and this may be a positive aspect to perhaps highlight during the consent process. Our findings highlight the importance of understanding the patient’s perspective on cosmesis as well as the day-to-day functionality perceived with aneurysmal AVF.

Rates of aneurysmal formation varied between units, which certainly merits further research. Further quantitative analysis such as sizes, cannulation practice, or survival analysis specific to this cohort would be useful. If the reasons for such differences could be quantified, (e.g. cannulation practices), then this could form the basis for an educational or procedural intervention to help enact change in practice, in line with patient satisfaction.

Acknowledgements

Mr Kamlesh Patel and Mr Dilan Dabare for the contribution to data collection.

Author contributions

AK, JE & MF – design, data collection, analysis, write up of articleJH & NI – design, analysis, write up of article.

Funding

This study was not supported by any external funding.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethics approval and consent to participate

This study utilised data collected as part of routine service evaluation to assess patients’ perspectives on their dialysis management. This was an extension of a previous service evaluation performed at our tertiary referral centre (Field et al. 2019 BMC Nephrology) and used a previously validated tool to quantify patients’ satisfaction with their vascular access (Vascular Access Questionnaire; VAQ). The study was approved by the audit committee at our institution (CARMS-16320). Since no interventions were performed, with patients only required to complete a questionnaire, formal ethical approval was not deemed to be required. Patients were informed that participation in the study was optional, and all included patients gave verbal informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Fluck R Kumwenda M Renal Association Clinical Practice Guideline on Vascular Access for Haemodialysis Nephron Clin Pract 2011 118 c225 40 10.1159/000328071 21555898
Fluck R, Kumwenda M. Renal Association Clinical Practice Guideline on Vascular Access for Haemodialysis. Nephron Clin Pract. 2011;118:c225–40.21555898 10.1159/000328071
2. Tordoir J Canaud B Haage P Konner K Basci A Fouque D EBPG on Vascular Access Nephrol Dial Transpl 2007 22 ii88 117 10.1093/ndt/gfm021
Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, et al. EBPG on Vascular Access. Nephrol Dial Transpl. 2007;22:ii88–117.10.1093/ndt/gfm021
3. Gallieni M Hollenbeck M Inston N Kumwenda M Powell S Tordoir J Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults Nephrol Dial Transpl 2019 34 ii1 42 10.1093/ndt/gfz072
Gallieni M, Hollenbeck M, Inston N, Kumwenda M, Powell S, Tordoir J, et al. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults. Nephrol Dial Transpl. 2019;34:ii1–42.10.1093/ndt/gfz072
4. Schmidli J, Widmer MK, Basile C, de Donato G, Gallieni M, Gibbons CP et al. Editor’s Choice 2018 Vascular Access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 55 757–818.
5. Polkinghorne P KR, Chin GK, MacGinley RJ, Owen AR, Russell C, Talaulikar GS, et al. KHA-CARI Guideline: vascular access - central venous catheters, arteriovenous fistulae and arteriovenous grafts. Nephrol (Carlton). 2013;18(11):701–5. 10.1111/nep.12132. Erratum in: Nephrology (Carlton). 2014;19(1):64. PMID: 23855977.
6. Lok CE Huber TS Lee T Shenoy S Yevzlin AS Abreo K KDOQI Clinical Practice Guideline for Vascular Access: 2019 update Am J Kidney Dis 2020 75 S1 164 10.1053/j.ajkd.2019.12.001 32778223
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis. 2020;75:S1–164.32778223 10.1053/j.ajkd.2019.12.001
7. Aiyegbusi OL Kyte D Cockwell P Marshall T Gheorghe A Keeley T Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review PLoS ONE 2017 12 e0179733 10.1371/journal.pone.0179733 28636678
Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Gheorghe A, Keeley T, et al. Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review. PLoS ONE. 2017;12:e0179733.28636678 10.1371/journal.pone.0179733
8. Tong A Manns B Hemmelgarn B Wheeler DC Evangelidis N Tugwell P Establishing Core Outcome domains in Hemodialysis: report of the standardized outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop Am J Kidney Dis 2017 69 97 107 10.1053/j.ajkd.2016.05.022 27497527
Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, et al. Establishing Core Outcome domains in Hemodialysis: report of the standardized outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis. 2017;69:97–107.27497527 10.1053/j.ajkd.2016.05.022
9. Viecelli AK Tong A O’Lone E Ju a Hanson CS Sautenet B Report of the standardized outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on establishing a core outcome measure for Hemodialysis Vascular Access Am J Kidney Dis 2018 71 690 700 10.1053/j.ajkd.2017.12.003 29478866
Viecelli AK, Tong A, O’Lone E, Ju a, Hanson CS, Sautenet B, et al. Report of the standardized outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on establishing a core outcome measure for Hemodialysis Vascular Access. Am J Kidney Dis. 2018;71:690–700.29478866 10.1053/j.ajkd.2017.12.003
10. Pasklinsky G Meisner RJ Labropoulos N Leon L Gasparis AP Landau D Management of true aneurysms of hemodialysis access fistulas J Vasc Surg 2011 53 1291 7 10.1016/j.jvs.2010.11.100 21276676
Pasklinsky G, Meisner RJ, Labropoulos N, Leon L, Gasparis AP, Landau D, et al. Management of true aneurysms of hemodialysis access fistulas. J Vasc Surg. 2011;53:1291–7.21276676 10.1016/j.jvs.2010.11.100
11. Valenti D Mistry H Stephenson M A novel classification system for Autogenous Arteriovenous Fistula aneurysms in Renal Access patients Vasc Endovascular Surg 2014 48 491 6 10.1177/1538574414561229 25487245
Valenti D, Mistry H, Stephenson M. A novel classification system for Autogenous Arteriovenous Fistula aneurysms in Renal Access patients. Vasc Endovascular Surg. 2014;48:491–6.25487245 10.1177/1538574414561229
12. Fokou M Teyang A Ashuntantang G Kaze F Eyenga VC Mefire AC Complications of Arteriovenous Fistula for Hemodialysis: an 8-Year study Ann Vasc Surg 2012 26 680 4 10.1016/j.avsg.2011.09.014 22534263
Fokou M, Teyang A, Ashuntantang G, Kaze F, Eyenga VC, Mefire AC, et al. Complications of Arteriovenous Fistula for Hemodialysis: an 8-Year study. Ann Vasc Surg. 2012;26:680–4.22534263 10.1016/j.avsg.2011.09.014
13. Ghoreyshi Z Amerian M Amanpour F Ebrahimi H Evaluation and comparison of the effects of Xyla-P cream and cold compress on the pain caused by the cannulation of arteriovenous fistula in hemodialysis patients Saudi J Kidney Dis Transpl 2018 29 369 75 10.4103/1319-2442.229265 29657205
Ghoreyshi Z, Amerian M, Amanpour F, Ebrahimi H. Evaluation and comparison of the effects of Xyla-P cream and cold compress on the pain caused by the cannulation of arteriovenous fistula in hemodialysis patients. Saudi J Kidney Dis Transpl. 2018;29:369–75.29657205 10.4103/1319-2442.229265
14. Balaz P Björck M True aneurysm in autologous hemodialysis fistulae: definitions, classification and indications for treatment J Vasc Access 2015 16 446 53 10.5301/jva.5000391 26044900
Balaz P, Björck M. True aneurysm in autologous hemodialysis fistulae: definitions, classification and indications for treatment. J Vasc Access. 2015;16:446–53.26044900 10.5301/jva.5000391
15. Baláž P Rokošný S Bafrnec J Whitley A O’Neill S Repair of Aneurysmal Arteriovenous Fistulae: a systematic review and Meta-analysis Eur J Vasc Endovasc Surg 2020 59 614 23 10.1016/j.ejvs.2019.07.033 31879147
Baláž P, Rokošný S, Bafrnec J, Whitley A, O’Neill S. Repair of Aneurysmal Arteriovenous Fistulae: a systematic review and Meta-analysis. Eur J Vasc Endovasc Surg. 2020;59:614–23.31879147 10.1016/j.ejvs.2019.07.033
16. Inston N Mistry H Gilbert J Kingsmore D Raza Z Tozzi M Aneurysms in Vascular Access: state of the art and future developments J Vasc Access 2017 18 464 72 10.5301/jva.5000828 29099536
Inston N, Mistry H, Gilbert J, Kingsmore D, Raza Z, Tozzi M, et al. Aneurysms in Vascular Access: state of the art and future developments. J Vasc Access. 2017;18:464–72.29099536 10.5301/jva.5000828
17. Xi W Harwood L Diamant MJ Brown JB Gallo K Sontrop JM Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making Nephrol Dial Transpl 2011 26 3302 8 10.1093/ndt/gfr055
Xi W, Harwood L, Diamant MJ, Brown JB, Gallo K, Sontrop JM, et al. Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making. Nephrol Dial Transpl. 2011;26:3302–8.10.1093/ndt/gfr055
18. Shamasneh AO Atieh AS Gharaibeh KA Hamadah A Perceived barriers and attitudes toward arteriovenous fistula creation and use in hemodialysis patients in Palestine Ren Fail 2020 42 343 9 10.1080/0886022X.2020.1748650 32338112
Shamasneh AO, Atieh AS, Gharaibeh KA, Hamadah A. Perceived barriers and attitudes toward arteriovenous fistula creation and use in hemodialysis patients in Palestine. Ren Fail. 2020;42:343–9.32338112 10.1080/0886022X.2020.1748650
19. Field M Tullett K Khawaja A Jones R Inston NG Quality improvement in vascular access: the role of patient-reported outcome measures J Vasc Access 2020 21 19 25 10.1177/1129729819845624 31081441
Field M, Tullett K, Khawaja A, Jones R, Inston NG, et al. Quality improvement in vascular access: the role of patient-reported outcome measures. J Vasc Access. 2020;21:19–25.31081441 10.1177/1129729819845624
20. Viecelli AK O’Lone E Sautenet B Craig JC Tong A Chemla E Vascular Access outcomes reported in maintenance hemodialysis trials: a systematic review Am J Kidney Dis 2018 71 382 91 10.1053/j.ajkd.2017.09.018 29203125
Viecelli AK, O’Lone E, Sautenet B, Craig JC, Tong A, Chemla E, et al. Vascular Access outcomes reported in maintenance hemodialysis trials: a systematic review. Am J Kidney Dis. 2018;71:382–91.29203125 10.1053/j.ajkd.2017.09.018
21. Quinn RR Lamping DL Lok CE Meyer RA HIller JA Lee J The Vascular Access Questionnaire: assessing patient-reported views of Vascular Access J Vasc Access 2008 9 122 8 10.1177/112972980800900208 18609528
Quinn RR, Lamping DL, Lok CE, Meyer RA, HIller JA, Lee J, et al. The Vascular Access Questionnaire: assessing patient-reported views of Vascular Access. J Vasc Access. 2008;9:122–8.18609528 10.1177/112972980800900208
22. Kosa SD Bhola C Lok CE Measuring patient satisfaction with Vascular Access: Vascular Access Questionnaire Development and Reliability Testing J Vasc Access 2015 16 200 5 10.5301/jva.5000339 25634153
Kosa SD, Bhola C, Lok CE. Measuring patient satisfaction with Vascular Access: Vascular Access Questionnaire Development and Reliability Testing. J Vasc Access. 2015;16:200–5.25634153 10.5301/jva.5000339
23. Kosa SD Bhola C Lok CE Hemodialysis patients’ satisfaction and perspectives on complications associated with Vascular Access related interventions: are we listening? J Vasc Access 2016 17 313 9 10.5301/jva.5000560 27312766
Kosa SD, Bhola C, Lok CE. Hemodialysis patients’ satisfaction and perspectives on complications associated with Vascular Access related interventions: are we listening? J Vasc Access. 2016;17:313–9.27312766 10.5301/jva.5000560
24. Field M Khawaja A Ellis J Nieto T Hodson J Inston N The vascular access questionnaire: a single centre UK experience BMC Nephrol 2019 20 299 10.1186/s12882-019-1493-9 31382916
Field M, Khawaja A, Ellis J, Nieto T, Hodson J, Inston N. The vascular access questionnaire: a single centre UK experience. BMC Nephrol. 2019;20:299.31382916 10.1186/s12882-019-1493-9
25. Harris PA Taylor R Thielke R Payne J Gonzalez, Conde JG Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support J Biomed Inf 2009 42 377 81 10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377–81.10.1016/j.jbi.2008.08.010
26. De Rango P Farchioni L Fiorucci B Lenti M Diabetes and abdominal aortic aneurysms Eur J Vasc Endovasc Surg 2014 47 243 61 10.1016/j.ejvs.2013.12.007 24447529
De Rango P, Farchioni L, Fiorucci B, Lenti M. Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014;47:243–61.24447529 10.1016/j.ejvs.2013.12.007
27. Patel K Zafar MA Ziganshin BA Elefteriades JA Diabetes Mellitus: is it protective against Aneurysm? A narrative review Cardiology 2018 141 107 22 10.1159/000490373 30453299
Patel K, Zafar MA, Ziganshin BA, Elefteriades JA. Diabetes Mellitus: is it protective against Aneurysm? A narrative review. Cardiology. 2018;141:107–22.30453299 10.1159/000490373
28. Inston N, Khawaja A, Tullett K, Jones R. WavelinQ created arteriovenous fistulas versus surgical radiocephalic arteriovenous fistulas? A single-centre observational study. J Vasc Access; 21. Epub ahead of print 2020. 10.1177/1129729819897168
